SIMILAR PATTERNS OF AMINO ACIDS FOR 2AVD_B_SAMB601_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b3j MHC CLASS I HOMOLOG
MIC-A


(Homo sapiens)
PF00129
(MHC_I)
PF07654
(C1-set)
3 SER A 174
GLU A  62
ASP A 163
None
0.84A 2avdB-1b3jA:
undetectable
2avdB-1b3jA:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bou 4,5-DIOXYGENASE
ALPHA CHAIN


(Sphingomonas
paucimobilis)
PF07746
(LigA)
3 SER A  43
GLU A  63
ASP A  56
None
0.82A 2avdB-1bouA:
undetectable
2avdB-1bouA:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ev1 ECHOVIRUS 1
ECHOVIRUS 1


(Enterovirus B;
Enterovirus B)
PF00073
(Rhv)
PF00073
(Rhv)
3 SER 1  62
GLU 3  48
ASP 3 220
None
0.76A 2avdB-1ev11:
undetectable
2avdB-1ev11:
18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ey1 ANTITERMINATION
FACTOR NUSB


(Escherichia
coli)
PF01029
(NusB)
3 SER A  71
GLU A  81
ASP A 118
None
0.90A 2avdB-1ey1A:
undetectable
2avdB-1ey1A:
24.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hjo PROTEIN (HEAT-SHOCK
70KD PROTEIN)


(Homo sapiens)
PF00012
(HSP70)
3 SER A 153
GLU A 117
ASP A  97
None
0.91A 2avdB-1hjoA:
undetectable
2avdB-1hjoA:
19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hxm GAMMA-DELTA T-CELL
RECEPTOR


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
3 SER B 179
GLU B 169
ASP B 222
None
0.85A 2avdB-1hxmB:
undetectable
2avdB-1hxmB:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m1c MAJOR COAT PROTEIN

(Saccharomyces
cerevisiae
virus L-A)
PF09220
(LA-virus_coat)
3 SER A 424
GLU A  71
ASP A  81
None
0.87A 2avdB-1m1cA:
undetectable
2avdB-1m1cA:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m22 PEPTIDE AMIDASE

(Stenotrophomonas
maltophilia)
PF01425
(Amidase)
3 SER A  64
GLU A 105
ASP A 156
None
0.85A 2avdB-1m22A:
undetectable
2avdB-1m22A:
19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m2p CASEIN KINASE II,
ALPHA CHAIN


(Zea mays)
PF00069
(Pkinase)
3 SER A   7
GLU A 201
ASP A 214
None
0.79A 2avdB-1m2pA:
undetectable
2avdB-1m2pA:
20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mqt POLYPROTEIN
POLYPROTEIN CAPSID
PROTEIN


(Enterovirus B;
Enterovirus B)
PF00073
(Rhv)
PF00073
(Rhv)
3 SER A  62
GLU C  48
ASP C 219
None
0.70A 2avdB-1mqtA:
undetectable
2avdB-1mqtA:
19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qjm LACTOFERRIN

(Equus caballus)
PF00405
(Transferrin)
3 SER A 634
GLU A 413
ASP A 395
None
None
CO3  A 693 ( 2.7A)
0.91A 2avdB-1qjmA:
undetectable
2avdB-1qjmA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r3d CONSERVED
HYPOTHETICAL PROTEIN
VC1974


(Vibrio cholerae)
PF12697
(Abhydrolase_6)
3 SER A 163
GLU A 117
ASP A  30
None
0.82A 2avdB-1r3dA:
2.6
2avdB-1r3dA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u2v ACTIN-RELATED
PROTEIN 3


(Bos taurus)
PF00022
(Actin)
3 SER A 297
GLU A 280
ASP A 237
None
0.63A 2avdB-1u2vA:
undetectable
2avdB-1u2vA:
19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v9k RIBOSOMAL LARGE
SUBUNIT
PSEUDOURIDINE
SYNTHASE C


(Escherichia
coli)
PF00849
(PseudoU_synth_2)
3 SER A 120
GLU A 204
ASP A 144
None
0.56A 2avdB-1v9kA:
undetectable
2avdB-1v9kA:
23.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xog NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
3 SER A 447
GLU A 231
ASP A 126
None
0.70A 2avdB-1xogA:
undetectable
2avdB-1xogA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y3n ALGQ1

(Sphingomonas
sp. A1)
PF01547
(SBP_bac_1)
3 SER A 202
GLU A 305
ASP A 269
None
0.65A 2avdB-1y3nA:
undetectable
2avdB-1y3nA:
17.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ylo HYPOTHETICAL PROTEIN
SF2450


(Shigella
flexneri)
PF05343
(Peptidase_M42)
3 SER A 170
GLU A 198
ASP A 249
None
ZN  A1446 ( 4.6A)
None
0.73A 2avdB-1yloA:
undetectable
2avdB-1yloA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ahw PUTATIVE ENZYME YDIF

(Escherichia
coli)
PF01144
(CoA_trans)
3 SER A  67
GLU A  42
ASP A  73
None
0.77A 2avdB-2ahwA:
undetectable
2avdB-2ahwA:
18.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2avd CATECHOL-O-METHYLTRA
NSFERASE


(Homo sapiens)
PF01596
(Methyltransf_3)
3 SER A 116
GLU A 134
ASP A 187
SAM  A 501 (-3.0A)
SAM  A 501 (-2.9A)
SAM  A 501 (-3.8A)
0.09A 2avdB-2avdA:
40.7
2avdB-2avdA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cxj S100 CALCIUM-BINDING
PROTEIN A13


(Mus musculus)
PF01023
(S_100)
3 SER A  69
GLU A  86
ASP A  52
None
0.78A 2avdB-2cxjA:
undetectable
2avdB-2cxjA:
17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2d3i OVOTRANSFERRIN

(Gallus gallus)
PF00405
(Transferrin)
3 SER A 630
GLU A 413
ASP A 395
None
None
AL  A 689 ( 3.0A)
0.87A 2avdB-2d3iA:
undetectable
2avdB-2d3iA:
14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2db3 ATP-DEPENDENT RNA
HELICASE VASA


(Drosophila
melanogaster)
PF00270
(DEAD)
PF00271
(Helicase_C)
3 SER A 293
GLU A 400
ASP A 571
ANP  A2901 (-3.8A)
ANP  A2901 (-4.3A)
None
0.89A 2avdB-2db3A:
4.2
2avdB-2db3A:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eho GINS COMPLEX SUBUNIT
3


(Homo sapiens)
PF05916
(Sld5)
3 SER D 152
GLU D 172
ASP D 108
None
0.69A 2avdB-2ehoD:
undetectable
2avdB-2ehoD:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2epg HYPOTHETICAL PROTEIN
TTHA1785


(Thermus
thermophilus)
PF01139
(RtcB)
3 SER A 397
GLU A 457
ASP A 216
None
0.75A 2avdB-2epgA:
undetectable
2avdB-2epgA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ije GUANINE
NUCLEOTIDE-RELEASING
PROTEIN


(Mus musculus)
PF00617
(RasGEF)
3 SER S1124
GLU S1085
ASP S1239
None
0.77A 2avdB-2ijeS:
undetectable
2avdB-2ijeS:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2inp PHENOL HYDROXYLASE
COMPONENT PHN


(Pseudomonas
stutzeri)
PF02332
(Phenol_Hydrox)
PF04945
(YHS)
3 SER A  89
GLU A 357
ASP A 281
None
0.76A 2avdB-2inpA:
undetectable
2avdB-2inpA:
16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nzu CATABOLITE CONTROL
PROTEIN
PHOSPHOCARRIER
PROTEIN HPR


(Bacillus
megaterium;
Bacillus
megaterium)
PF13377
(Peripla_BP_3)
PF00381
(PTS-HPr)
3 SER L  12
GLU G  77
ASP G  84
SO4  L 975 (-4.0A)
None
None
0.88A 2avdB-2nzuL:
undetectable
2avdB-2nzuL:
14.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rag DIPEPTIDASE

(Caulobacter
vibrioides)
PF01244
(Peptidase_M19)
3 SER A 282
GLU A 371
ASP A 326
None
0.83A 2avdB-2ragA:
undetectable
2avdB-2ragA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rmn TUMOR PROTEIN 63

(Homo sapiens)
PF00870
(P53)
3 SER A 271
GLU A 302
ASP A 316
None
0.54A 2avdB-2rmnA:
undetectable
2avdB-2rmnA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w1v NITRILASE HOMOLOG 2

(Mus musculus)
PF00795
(CN_hydrolase)
3 SER A  78
GLU A  81
ASP A 193
None
0.84A 2avdB-2w1vA:
undetectable
2avdB-2w1vA:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wa2 NON-STRUCTURAL
PROTEIN 5


(Modoc virus)
PF01728
(FtsJ)
3 SER A 239
GLU A  11
ASP A 192
None
0.87A 2avdB-2wa2A:
9.3
2avdB-2wa2A:
23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zkg E3 UBIQUITIN-PROTEIN
LIGASE UHRF1


(Mus musculus)
PF02182
(SAD_SRA)
3 SER A 575
GLU A 571
ASP A 474
None
0.83A 2avdB-2zkgA:
undetectable
2avdB-2zkgA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c1o EUGENOL SYNTHASE

(Clarkia breweri)
PF05368
(NmrA)
3 SER A 266
GLU A 125
ASP A 116
None
0.72A 2avdB-3c1oA:
6.6
2avdB-3c1oA:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cih PUTATIVE
ALPHA-RHAMNOSIDASE


(Bacteroides
thetaiotaomicron)
PF17389
(Bac_rhamnosid6H)
PF17390
(Bac_rhamnosid_C)
3 SER A 463
GLU A 456
ASP A 436
None
0.80A 2avdB-3cihA:
undetectable
2avdB-3cihA:
14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dg7 MUCONATE
CYCLOISOMERASE


(Mycolicibacterium
smegmatis)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
3 SER A 201
GLU A 218
ASP A 223
None
0.90A 2avdB-3dg7A:
undetectable
2avdB-3dg7A:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e5d PUTATIVE GLYOXALASE
I


(Listeria
monocytogenes)
PF00903
(Glyoxalase)
3 SER A 112
GLU A  89
ASP A  94
None
0.83A 2avdB-3e5dA:
undetectable
2avdB-3e5dA:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ekm DIAMINOPIMELATE
EPIMERASE,
CHLOROPLASTIC


(Arabidopsis
thaliana)
PF01678
(DAP_epimerase)
3 SER A  94
GLU A 245
ASP A  38
None
ZDR  A 500 (-3.0A)
None
0.91A 2avdB-3ekmA:
undetectable
2avdB-3ekmA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eno PUTATIVE
O-SIALOGLYCOPROTEIN
ENDOPEPTIDASE


(Thermoplasma
acidophilum)
PF00814
(Peptidase_M22)
3 SER A 300
GLU A 113
ASP A 123
None
0.69A 2avdB-3enoA:
undetectable
2avdB-3enoA:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3faw RETICULOCYTE BINDING
PROTEIN


(Streptococcus
agalactiae)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
3 SER A 568
GLU A 571
ASP A 511
None
0.76A 2avdB-3fawA:
undetectable
2avdB-3fawA:
14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h7l ENDOGLUCANASE

(Vibrio
parahaemolyticus)
PF00759
(Glyco_hydro_9)
PF02927
(CelD_N)
3 SER A  73
GLU A  11
ASP A 182
None
0.72A 2avdB-3h7lA:
undetectable
2avdB-3h7lA:
17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hbj FLAVONOID
3-O-GLUCOSYLTRANSFER
ASE


(Medicago
truncatula)
PF00201
(UDPGT)
3 SER A 353
GLU A 385
ASP A 395
None
0.69A 2avdB-3hbjA:
5.2
2avdB-3hbjA:
21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3igq GLR4197 PROTEIN

(Gloeobacter
violaceus)
PF02931
(Neur_chan_LBD)
3 SER A 107
GLU A  82
ASP A  31
None
0.91A 2avdB-3igqA:
undetectable
2avdB-3igqA:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ixw HEMOCYANIN AA6 CHAIN

(Androctonus
australis)
PF00372
(Hemocyanin_M)
PF03722
(Hemocyanin_N)
PF03723
(Hemocyanin_C)
3 SER A 524
GLU A 529
ASP A 585
None
0.83A 2avdB-3ixwA:
undetectable
2avdB-3ixwA:
16.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k9d ALDEHYDE
DEHYDROGENASE


(Listeria
monocytogenes)
PF00171
(Aldedh)
3 SER A 362
GLU A 260
ASP A 381
None
0.81A 2avdB-3k9dA:
4.9
2avdB-3k9dA:
17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mc2 INHIBITOR OF
CARBONIC ANHYDRASE


(Mus musculus)
PF00405
(Transferrin)
3 SER A 626
GLU A 404
ASP A 386
None
0.74A 2avdB-3mc2A:
undetectable
2avdB-3mc2A:
17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3meb ASPARTATE
AMINOTRANSFERASE


(Giardia
intestinalis)
PF00155
(Aminotran_1_2)
3 SER A 286
GLU A  96
ASP A 243
None
None
EDO  A 505 (-3.6A)
0.88A 2avdB-3mebA:
2.4
2avdB-3mebA:
20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mga ENTEROCHELIN
ESTERASE


(Salmonella
enterica)
PF00756
(Esterase)
PF11806
(DUF3327)
3 SER A 291
GLU A 248
ASP A 238
None
0.81A 2avdB-3mgaA:
undetectable
2avdB-3mgaA:
23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mgx PUTATIVE P450
MONOOXYGENASE


(Amycolatopsis
balhimycina)
PF00067
(p450)
3 SER A 280
GLU A 274
ASP A 322
None
0.90A 2avdB-3mgxA:
undetectable
2avdB-3mgxA:
22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nvq SEMAPHORIN-7A

(Homo sapiens)
PF01403
(Sema)
PF01437
(PSI)
PF13895
(Ig_2)
3 SER A 520
GLU A 102
ASP A 471
None
0.53A 2avdB-3nvqA:
undetectable
2avdB-3nvqA:
17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oum TOXOFLAVIN-DEGRADING
ENZYME


(Paenibacillus
polymyxa)
PF00903
(Glyoxalase)
3 SER A 116
GLU A  72
ASP A 125
None
0.81A 2avdB-3oumA:
undetectable
2avdB-3oumA:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tho EXONUCLEASE,
PUTATIVE


(Thermotoga
maritima)
PF00149
(Metallophos)
3 SER B  21
GLU B 242
ASP B  14
None
None
MN  B   1 (-3.7A)
0.90A 2avdB-3thoB:
undetectable
2avdB-3thoB:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tlm SARCOPLASMIC/ENDOPLA
SMIC RETICULUM
CALCIUM ATPASE 1


(Bos taurus)
PF00122
(E1-E2_ATPase)
PF00689
(Cation_ATPase_C)
PF00690
(Cation_ATPase_N)
PF08282
(Hydrolase_3)
PF13246
(Cation_ATPase)
3 SER A 404
GLU A 394
ASP A 399
None
0.86A 2avdB-3tlmA:
undetectable
2avdB-3tlmA:
11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tx7 NUCLEAR RECEPTOR
SUBFAMILY 5 GROUP A
MEMBER 2


(Homo sapiens)
PF00104
(Hormone_recep)
3 SER B 362
GLU B 312
ASP B 389
None
0.78A 2avdB-3tx7B:
undetectable
2avdB-3tx7B:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u1k POLYRIBONUCLEOTIDE
NUCLEOTIDYLTRANSFERA
SE 1, MITOCHONDRIAL


(Homo sapiens)
PF00013
(KH_1)
PF01138
(RNase_PH)
PF03725
(RNase_PH_C)
PF03726
(PNPase)
3 SER A 503
GLU A 234
ASP A 420
None
0.87A 2avdB-3u1kA:
undetectable
2avdB-3u1kA:
17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u4a JMB19063

(compost
metagenome)
PF00933
(Glyco_hydro_3)
PF01915
(Glyco_hydro_3_C)
PF14310
(Fn3-like)
3 SER A 649
GLU A 656
ASP A 727
None
0.60A 2avdB-3u4aA:
undetectable
2avdB-3u4aA:
15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wec CYTOCHROME P450

(Rhodococcus
erythropolis)
PF00067
(p450)
3 SER A 179
GLU A 159
ASP A 169
None
0.83A 2avdB-3wecA:
undetectable
2avdB-3wecA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wj7 PUTATIVE
OXIDOREDUCTASE


(Gluconobacter
oxydans)
PF01370
(Epimerase)
3 SER A 179
GLU A 242
ASP A 323
None
0.82A 2avdB-3wj7A:
5.9
2avdB-3wj7A:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a2q RETINOIC ACID
INDUCIBLE PROTEIN I


(Anas
platyrhynchos)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF16739
(CARD_2)
3 SER A 642
GLU A 570
ASP A 117
None
0.88A 2avdB-4a2qA:
undetectable
2avdB-4a2qA:
14.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aio LIMIT DEXTRINASE

(Hordeum vulgare)
PF02922
(CBM_48)
PF11852
(DUF3372)
3 SER A 445
GLU A 516
ASP A 513
None
0.90A 2avdB-4aioA:
undetectable
2avdB-4aioA:
14.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bed HEMOCYANIN KLH1

(Megathura
crenulata)
PF00264
(Tyrosinase)
PF14830
(Haemocyan_bet_s)
3 SER B2990
GLU B2919
ASP B3175
None
0.69A 2avdB-4bedB:
undetectable
2avdB-4bedB:
8.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bl0 CELL CYCLE ARREST
PROTEIN BUB3
CHECKPOINT
SERINE/THREONINE-PRO
TEIN KINASE BUB1


(Saccharomyces
cerevisiae;
Saccharomyces
cerevisiae)
PF00400
(WD40)
PF08171
(Mad3_BUB1_II)
3 SER A 312
GLU B 337
ASP A 198
None
None
MG  A1341 (-2.9A)
0.74A 2avdB-4bl0A:
undetectable
2avdB-4bl0A:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eg2 CYTIDINE DEAMINASE

(Vibrio cholerae)
PF00383
(dCMP_cyt_deam_1)
PF08211
(dCMP_cyt_deam_2)
3 SER A 164
GLU A 138
ASP A 173
None
0.86A 2avdB-4eg2A:
undetectable
2avdB-4eg2A:
24.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4euf PUTATIVE REDUCTASE
CA_C0462


(Clostridium
acetobutylicum)
PF07055
(Eno-Rase_FAD_bd)
PF12241
(Enoyl_reductase)
PF12242
(Eno-Rase_NADH_b)
3 SER A 279
GLU A 370
ASP A 363
NAD  A1001 ( 4.9A)
None
None
0.90A 2avdB-4eufA:
7.0
2avdB-4eufA:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fwi ABC-TYPE
DIPEPTIDE/OLIGOPEPTI
DE/NICKEL TRANSPORT
SYSTEM, ATPASE
COMPONENT


(Caldanaerobacter
subterraneus)
PF00005
(ABC_tran)
PF08352
(oligo_HPY)
3 SER B 257
GLU B  42
ASP B 274
None
0.74A 2avdB-4fwiB:
undetectable
2avdB-4fwiB:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4is8 NUCLEAR RECEPTOR
SUBFAMILY 5 GROUP A
MEMBER 2


(Homo sapiens)
PF00104
(Hormone_recep)
3 SER A 362
GLU A 312
ASP A 389
None
0.78A 2avdB-4is8A:
undetectable
2avdB-4is8A:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jr7 CASEIN KINASE II
SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00069
(Pkinase)
3 SER A   7
GLU A 240
ASP A 253
None
0.74A 2avdB-4jr7A:
undetectable
2avdB-4jr7A:
18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lg4 SERINE/THREONINE-PRO
TEIN KINASE 3


(Homo sapiens)
PF00069
(Pkinase)
3 SER A  88
GLU A  70
ASP A  63
None
0.84A 2avdB-4lg4A:
undetectable
2avdB-4lg4A:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ls3 NICKEL (III) ABC
TRANSPORTER,
PERIPLASMIC
IRON-BINDIN GPROTEIN


(Helicobacter
pylori)
PF01497
(Peripla_BP_2)
3 SER A  59
GLU A 150
ASP A 211
HIS  A 601 ( 4.8A)
None
None
0.81A 2avdB-4ls3A:
undetectable
2avdB-4ls3A:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4md8 CASEIN KINASE II
SUBUNIT ALPHA


(Homo sapiens)
PF00069
(Pkinase)
3 SER E   7
GLU E 201
ASP E 214
None
0.82A 2avdB-4md8E:
undetectable
2avdB-4md8E:
18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n3s EUKARYOTIC
TRANSLATION
INITIATION FACTOR 5B


(Saccharomyces
cerevisiae)
PF00009
(GTP_EFTU)
PF03144
(GTP_EFTU_D2)
PF11987
(IF-2)
3 SER A 579
GLU A 571
ASP A 502
None
0.89A 2avdB-4n3sA:
undetectable
2avdB-4n3sA:
18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o2x MALTOSE-BINDING
PERIPLASMIC PROTEIN,
ATP-DEPENDENT CLP
PROTEASE ADAPTOR
PROTEIN CLPS
CONTAINING PROTEIN
CHIMERIC CONSTRUCT


(Escherichia
coli;
Plasmodium
falciparum)
PF02617
(ClpS)
PF13416
(SBP_bac_8)
3 SER A 407
GLU A 482
ASP A 208
None
0.81A 2avdB-4o2xA:
undetectable
2avdB-4o2xA:
18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o4x TBPB

(Glaesserella
parasuis)
PF01298
(TbpB_B_D)
PF17483
(TbpB_C)
PF17484
(TbpB_A)
3 SER A 286
GLU A 103
ASP A  98
None
None
GOL  A 601 ( 4.4A)
0.89A 2avdB-4o4xA:
undetectable
2avdB-4o4xA:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4om9 SERINE PROTEASE PET

(Escherichia
coli)
PF02395
(Peptidase_S6)
3 SER A  27
GLU A 577
ASP A 447
None
0.88A 2avdB-4om9A:
undetectable
2avdB-4om9A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ozi T-CELL RECEPTOR, S2,
BETA CHAIN


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
3 SER F  99
GLU F 126
ASP F 196
None
0.85A 2avdB-4oziF:
undetectable
2avdB-4oziF:
23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pet EXTRACELLULAR
SOLUTE-BINDING
PROTEIN, FAMILY 7


(Colwellia
psychrerythraea)
PF03480
(DctP)
3 SER A 200
GLU A  40
ASP A  51
None
0.77A 2avdB-4petA:
undetectable
2avdB-4petA:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q4y COXSACKIEVIRUS
CAPSID PROTEIN VP1
COXSACKIEVIRUS
CAPSID PROTEIN VP3


(Enterovirus C;
Enterovirus C)
PF00073
(Rhv)
PF00073
(Rhv)
3 SER 1  75
GLU 3  48
ASP 3 218
None
0.72A 2avdB-4q4y1:
undetectable
2avdB-4q4y1:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qmd ENVOPLAKIN

(Homo sapiens)
PF00681
(Plectin)
3 SER A1987
GLU A1995
ASP A1981
None
0.80A 2avdB-4qmdA:
undetectable
2avdB-4qmdA:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wbd BSHC

(Bacillus
subtilis)
PF10079
(BshC)
3 SER A  48
GLU A 339
ASP A  30
None
0.76A 2avdB-4wbdA:
undetectable
2avdB-4wbdA:
18.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xqk LLABIII

(Lactococcus
lactis)
PF00271
(Helicase_C)
PF02384
(N6_Mtase)
PF04851
(ResIII)
PF13156
(Mrr_cat_2)
3 SER A 788
GLU A 826
ASP A 424
None
0.73A 2avdB-4xqkA:
10.3
2avdB-4xqkA:
8.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ydi ENVELOPE
GLYCOPROTEIN GP160
HEAVY CHAIN OF
ANTIBODY
Z258-VRC27.01
LIGHT CHAIN OF
ANTIBODY
Z258-VRC27.01


(Human
immunodeficiency
virus 1;
Homo sapiens;
Homo sapiens)
PF00516
(GP120)
PF07654
(C1-set)
PF07686
(V-set)
PF07654
(C1-set)
PF07686
(V-set)
3 SER H 100
GLU L  96
ASP G 457
None
0.90A 2avdB-4ydiH:
undetectable
2avdB-4ydiH:
20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a99 POLYHEDRIN

(Operophtera
brumata
cypovirus 19)
no annotation 3 SER A 110
GLU A 225
ASP A 245
None
0.81A 2avdB-5a99A:
undetectable
2avdB-5a99A:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5aey PLASMID SEGREGATION
PROTEIN PARM


(Escherichia
coli)
PF06406
(StbA)
3 SER A 195
GLU A 148
ASP A   7
None
ANP  A 500 (-3.2A)
None
0.91A 2avdB-5aeyA:
undetectable
2avdB-5aeyA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5azb PROLIPOPROTEIN
DIACYLGLYCERYL
TRANSFERASE


(Escherichia
coli)
PF01790
(LGT)
3 SER A 198
GLU A 243
ASP A 249
None
0.70A 2avdB-5azbA:
undetectable
2avdB-5azbA:
22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b7i CRISPR-ASSOCIATED
NUCLEASE/HELICASE
CAS3 SUBTYPE
I-F/YPEST


(Pseudomonas
aeruginosa)
no annotation 3 SER A 776
GLU A1041
ASP A 471
None
0.60A 2avdB-5b7iA:
3.2
2avdB-5b7iA:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cm6 TRAP DICARBOXYLATE
TRANSPORTER-DCTP
SUBUNIT


(Pseudoalteromonas
atlantica)
PF03480
(DctP)
3 SER A 194
GLU A  34
ASP A  45
None
0.91A 2avdB-5cm6A:
undetectable
2avdB-5cm6A:
19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dkx ALPHA
GLUCOSIDASE-LIKE
PROTEIN


(Chaetomium
thermophilum)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
PF17137
(DUF5110)
3 SER A 258
GLU A 243
ASP A  40
None
0.72A 2avdB-5dkxA:
undetectable
2avdB-5dkxA:
11.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dx5 METHIONINE
GAMMA-LYASE


(Clostridium
sporogenes)
PF01053
(Cys_Met_Meta_PP)
3 SER A 378
GLU A 346
ASP A 219
None
0.81A 2avdB-5dx5A:
3.5
2avdB-5dx5A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ftx SURFACE LAYER
PROTEIN


(Geobacillus
stearothermophilus)
no annotation 3 SER A 606
GLU A 614
ASP A 660
None
None
CA  A2104 (-3.0A)
0.89A 2avdB-5ftxA:
undetectable
2avdB-5ftxA:
14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h71 ALGQ2

(Sphingomonas
sp.)
PF01547
(SBP_bac_1)
3 SER A 202
GLU A 305
ASP A 269
None
0.62A 2avdB-5h71A:
undetectable
2avdB-5h71A:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hh0 N-ALPHA-ACETYLTRANSF
ERASE 60


(Homo sapiens)
PF00583
(Acetyltransf_1)
3 SER A 125
GLU A 118
ASP A 154
None
0.80A 2avdB-5hh0A:
undetectable
2avdB-5hh0A:
23.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hjr NEUTRAL
ALPHA-GLUCOSIDASE AB


(Mus musculus)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
3 SER A 265
GLU A 250
ASP A  42
None
FMT  A1017 (-4.2A)
None
0.88A 2avdB-5hjrA:
undetectable
2avdB-5hjrA:
14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j68 ASTROTACTIN-2

(Homo sapiens)
PF01823
(MACPF)
3 SER A1232
GLU A 796
ASP A1111
None
0.89A 2avdB-5j68A:
undetectable
2avdB-5j68A:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lcw ANAPHASE-PROMOTING
COMPLEX SUBUNIT 1


(Homo sapiens)
PF12859
(ANAPC1)
3 SER A1349
GLU A1354
ASP A1361
None
0.91A 2avdB-5lcwA:
undetectable
2avdB-5lcwA:
8.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t76 ALANINE--TRNA
LIGASE, CYTOPLASMIC


(Homo sapiens)
PF02272
(DHHA1)
3 SER A  77
GLU A 139
ASP A  34
None
0.90A 2avdB-5t76A:
undetectable
2avdB-5t76A:
24.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uyr BACTERIOPHYTOCHROME

(Xanthomonas
campestris)
no annotation 3 SER A 496
GLU A 328
ASP A 333
None
0.85A 2avdB-5uyrA:
undetectable
2avdB-5uyrA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vni PROTEIN TRANSPORT
PROTEIN SEC24A
VESICLE-TRAFFICKING
PROTEIN SEC22B


(Homo sapiens;
Mus musculus)
PF00626
(Gelsolin)
PF04810
(zf-Sec23_Sec24)
PF04811
(Sec23_trunk)
PF04815
(Sec23_helical)
PF08033
(Sec23_BS)
PF13774
(Longin)
3 SER B 561
GLU B 582
ASP C 128
None
0.73A 2avdB-5vniB:
undetectable
2avdB-5vniB:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ynl ARGINASE

(Glaciozyma
antarctica)
no annotation 3 SER A 241
GLU A 288
ASP A 194
None
0.87A 2avdB-5ynlA:
2.8
2avdB-5ynlA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ysm CYTOCHROME P450

(Amycolatopsis
mediterranei)
no annotation 3 SER A 301
GLU A 295
ASP A 344
None
0.89A 2avdB-5ysmA:
undetectable
2avdB-5ysmA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6dft -

(-)
no annotation 3 SER A 220
GLU A 174
ASP A 205
None
0.69A 2avdB-6dftA:
undetectable
2avdB-6dftA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6exv DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB2


(Sus scrofa)
no annotation 3 SER B 893
GLU B 830
ASP B 850
None
0.89A 2avdB-6exvB:
undetectable
2avdB-6exvB:
undetectable